Roche Receives the US FDA’s EUA for cobas SARS-CoV-2 Test to Suspect COVID-19

 Roche Receives the US FDA’s EUA for cobas SARS-CoV-2 Test to Suspect COVID-19

Roche Receives the US FDA’s EUA for cobas SARS-CoV-2 Test to Suspect COVID-19

Shots:

  • Roche’s cobas SARS-CoV-2 test to be use on high-throughput cobas 6800/8800 systems has received the US FDA’s EUA for testing individuals without symptoms or reasons to control the spread of COVID-19
  • The authorization expands SARS-CoV-2 testing to include people without symptoms and applies to pooled samples containing up to and including 6 individual samples
  • Asymptomatic testing with the cobas SARS-CoV-2 test is available in countries accepting the CE mark

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Switzerland Global Enterprise

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post